Business

After Pfizer’s coronavirus boom, CEO in crosshairs over sales slump

It’s a sharp turn in fortune for Albert Bourla, who oversaw development and mass production of the novel RNA vaccine that helped get the pandemic under control and put the global economy back on track.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business